Clinical Trial Update: Lenalidomide for Adult Histiocyte Disorders [Phase 2]

View source ↗

Summary

Phase 2 trial results of lenalidomide in adults with Langerhans cell histiocytosis, Erdheim-Chester disease, and histiocytic sarcoma; the study is active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erdheim-chester Disease
• Histiocytic Sarcoma
• Langerhans Cell Histiocytosis

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Langerhans Cell Histiocytosis (LCH), Histiocytoses Erdheim-chester Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-04-25